Tan Tze Ping, Arekapudi Anil, Metha Jigesh, Prasad Arun, Venkatraghavan Lashmi
Department of Anaesthesia, Shepparton Hospital, Shepparton, Victoria, Australia.
Department of Anesthesia and Pain Management, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
ANZ J Surg. 2015 Jun;85(6):414-9. doi: 10.1111/ans.13036. Epub 2015 Mar 17.
Neutrophil-lymphocyte ratio (NLR) is an emerging biomarker of inflammation and predicts poorer outcome in cancer surgery. The prognostic value of NLR in cardiovascular surgery is unclear.
Systematic review and meta-analysis of studies of in cardiovascular surgical patients were conducted to assess the role of perioperative NLR in predicting post-operative mortality and morbidity. Electronic searches were conducted on Ovid Medline, EMBASE, Cochrane Central Register of Controlled Trials and Cochrane Database of Systemic Reviews for all prospective clinical studies reporting on NLR and post-operative morbidity and mortality in cardiovascular surgical patient population. Our primary end point was all-cause post-operative mortality and the secondary end point was post-operative morbidity. Mortality outcome from prospective studies were pooled for a meta-analysis using a random-effect model.
Of the 999 citations identified, five studies with 3487 patients met the inclusion criteria. In a pooled analysis of three prospective studies of 3108 patients, a preoperative increase in NLR (>3.3 in cardiac surgery, >5 in vascular surgery) was associated with increased mortality at a mean follow-up of 34.8 months (hazard ratio 1.85, 95% confidence interval 1.46-2.36; P < 0.00001). Raised NLR value was also associated with increased cardiac mortality, amputation in vascular operations and raised risk of post-operative re-intubation.
Elevated NLR were associated with increased long-term mortality and morbidity after major cardiac and vascular surgery. NLR may guide perioperative management and risk-stratification of patients.
中性粒细胞与淋巴细胞比值(NLR)是一种新出现的炎症生物标志物,可预测癌症手术的不良预后。NLR在心血管手术中的预后价值尚不清楚。
对心血管外科患者的研究进行系统评价和荟萃分析,以评估围手术期NLR在预测术后死亡率和发病率中的作用。在Ovid Medline、EMBASE、Cochrane对照试验中心注册库和Cochrane系统评价数据库中进行电子检索,查找所有报道心血管外科患者群体中NLR与术后发病率和死亡率的前瞻性临床研究。我们的主要终点是全因术后死亡率,次要终点是术后发病率。使用随机效应模型汇总前瞻性研究的死亡率结果进行荟萃分析。
在检索到的999篇文献中,5项研究共3487例患者符合纳入标准。在对3108例患者的3项前瞻性研究的汇总分析中,术前NLR升高(心脏手术中>3.3,血管手术中>5)与平均随访34.8个月时死亡率增加相关(风险比1.85,95%置信区间1.46 - 2.36;P < 0.00001)。NLR升高还与心脏死亡率增加、血管手术中的截肢以及术后再次插管风险增加相关。
NLR升高与心脏和大血管手术后长期死亡率和发病率增加相关。NLR可指导患者的围手术期管理和风险分层。